companies / bcnbio-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-05 json
| total_raised | 3,026,2903.0M | ○ |
|---|---|---|
| founded | null | |
| hq | PASADENA, California, USA | |
| industry | unknown | |
| stage | null |
BCN Biosciences is an early phase biotechnology corporation with core competencies in the oncology drug discovery market. We believe that working towards this vision and the progress we make will bring hope for a healthier world. BCN Biosciences is also paving the way for future products for early stage cancer detection.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2023-08-01 | grant | 3,000,0003.0M | null | ○ |
LiteSpeed
| fact | status | src |
|---|---|---|
| Grant, $3.0M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |